Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alzamend Neuro, Inc.ALZN · Entity 8081 | Chief Financial Officer | April 30, 2026 | August 05, 2026 |
| Ault Disruptive Technologies CorpADRT · Entity 87178 | Vice President - Finance | December 15, 2021 | December 16, 2021 |
| TurnOnGreen, Inc.IMHC · Entity 8456 | CFO, Secretary, Treasurer | June 26, 2023 | June 28, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alzamend Neuro, Inc.
Report date April 30, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.33 · Expires 2035-11-12 | Direct | 300,000 |
Reported balance
After 2026-04-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-17 · Grant · Acquired 300,000 · Balance 300,000 F1: On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Katzoff to purchase 300,000 shares of Common Stock. Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders. Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable. The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Katzoff to purchase 300,000 shares of Common Stock. Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders. Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable. The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026.
Ault Disruptive Technologies Corp
Report date December 15, 2021 · Filed December 16, 2021
This filing explicitly reported no securities owned.
TurnOnGreen, Inc.
Report date June 26, 2023 · Filed June 28, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,320 |
Reported balance
After 2023-06-26 transaction · row 1
1 source rowRow 1 · 2023-06-26 · Other · Acquired 13,320 · Balance 13,320 F1: The transaction is the receipt of 13,320 shares of common stock by the reporting person, for no consideration, in a distribution by Ault Alliance, Inc. to its stockholders. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2028-06-26 | Direct | 13,320 |
Reported balance
After 2023-06-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-26 · Other · Acquired 13,320 · Balance 13,320 F2: The transaction is the receipt of 13,320 warrants by the reporting person, for no consideration, in a distribution by Ault Alliance, Inc. to its stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction is the receipt of 13,320 shares of common stock by the reporting person, for no consideration, in a distribution by Ault Alliance, Inc. to its stockholders.
F2: The transaction is the receipt of 13,320 warrants by the reporting person, for no consideration, in a distribution by Ault Alliance, Inc. to its stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 17, 2026 Filed Aug 5, 2026 01:00 UTC | Alzamend Neuro, Inc. ALZN · Entity 8081 | GrantStock Options (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001214659-26-009585 · marketforms-73674.xml · derivative · entry 1 Katzoff David J · CIK 0001864317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2035-11-12 F1 · derivative.exercise_date: On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Katzoff to purchase 300,000 shares of Common Stock. Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders. Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable. The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 11:30 UTC | Alzamend Neuro, Inc. ALZN · Entity 8081 | PurchaseCommon Stock | 5,000 | $1.01 | $5,048.00 |
DisclosureSEC source: 0001214659-25-004643 · marketforms-68905.xml · nonDerivative · entry 1 Katzoff David J · CIK 0001864317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,540 Read SEC document |
| September 26, 2023 Filed Sep 26, 2023 22:01 UTC | Alzamend Neuro, Inc. ALZN · Entity 8081 | PurchaseCommon Stock | 53,000 | $0.19 | $10,234.30 |
DisclosureSEC source: 0001864317-23-000001 · primary_doc.xml · nonDerivative · entry 1 Katzoff David J · CIK 0001864317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,000 F1 · price: The common stock was bought by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $0.1931. The range of purchase prices on the transaction date was $0.19 to $0.1955 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares bought at each price. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 20:00 UTC | TurnOnGreen, Inc. IMHC · Entity 8456 | OtherWarrants · Derivative | 13,320 | Not disclosed Strike: $0.10 | Not disclosed |
DisclosureSEC source: 0001214659-23-008908 · marketforms-61990.xml · derivative · entry 2 Katzoff David J · CIK 0001864317 · CFO, Secretary, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,320 Underlying: Common Stock · 13,320 shares Expires 2028-06-26 F2 · kind: The transaction is the receipt of 13,320 warrants by the reporting person, for no consideration, in a distribution by Ault Alliance, Inc. to its stockholders. F2 · price: The transaction is the receipt of 13,320 warrants by the reporting person, for no consideration, in a distribution by Ault Alliance, Inc. to its stockholders. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 20:00 UTC | TurnOnGreen, Inc. IMHC · Entity 8456 | OtherCommon Stock | 13,320 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-23-008908 · marketforms-61990.xml · nonDerivative · entry 1 Katzoff David J · CIK 0001864317 · CFO, Secretary, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,320 F1 · kind: The transaction is the receipt of 13,320 shares of common stock by the reporting person, for no consideration, in a distribution by Ault Alliance, Inc. to its stockholders. F1 · price: The transaction is the receipt of 13,320 shares of common stock by the reporting person, for no consideration, in a distribution by Ault Alliance, Inc. to its stockholders. Read SEC document |
| September 14, 2022 Filed Sep 14, 2022 21:07 UTC | Alzamend Neuro, Inc. ALZN · Entity 8081 | PurchaseCommon Stock | 10,000 | $1.11 | $11,092.00 |
DisclosureSEC source: 0001864317-22-000007 · primary_doc.xml · nonDerivative · entry 1 Katzoff David J · CIK 0001864317 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.